Gene Therapy Promising in BCG-Unresponsive Bladder Cancer Gene Therapy Promising in BCG-Unresponsive Bladder Cancer
An investigative intravesical viral gene therapy may offer a bladder-sparing alternative for some patients with high-grade, nonmuscle invasive bladder cancer who have few options, results from a phase 3 study show.Medscape Medical News
Source: Medscape Urology Headlines - Category: Urology & Nephrology Tags: Urology News Source Type: news
More News: Bladder Cancer | Cancer | Cancer & Oncology | Gene Therapy | Genetics | Study | Urology & Nephrology